- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 217/08 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ringAlkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom
Patent holdings for IPC class C07D 217/08
Total number of patents in this class: 74
10-year publication summary
|
8
|
9
|
9
|
5
|
7
|
4
|
3
|
5
|
3
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| FUJIFILM Corporation | 29350 |
6 |
| Minerva Neurosciences, Inc. | 56 |
4 |
| Fosun Orinove Pharmatech, Inc. | 13 |
4 |
| Novartis AG | 10847 |
3 |
| The Regents of the University of California | 19898 |
3 |
| Biogen MA Inc. | 894 |
3 |
| Bristol-myers Squibb Company | 4878 |
2 |
| University of Florida Research Foundation, Inc. | 4018 |
2 |
| Epizyme, Inc. | 370 |
2 |
| Irm LLC | 161 |
2 |
| Ono Pharmaceutical Co., Ltd. | 434 |
2 |
| The University of Florida Board of Trustees, a Public Body Corporate of the State of Florida | 81 |
2 |
| Florida A&M University | 66 |
2 |
| Opna Bio SA | 28 |
2 |
| Atai Therapeutics, Inc. | 67 |
2 |
| Takeda Pharmaceutical Company Limited | 2714 |
1 |
| Alnylam Pharmaceuticals, Inc. | 1150 |
1 |
| Argusina, Inc. | 2 |
1 |
| Astellas Pharma Inc. | 1085 |
1 |
| Cancer Research Technology Limited | 522 |
1 |
| Other owners | 28 |